Cerus Corp (NASDAQ: CERS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CERUS CORP

Cerus Corp (NASDAQ: CERS)
Listen to this Section


$2.79
-0.0050 ( -0.18% ) 729.2K

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Market Data


Open $2.79
Previous Close $2.79
Volume 729.2K
Market Cap $559.03M
Day Range $2.68 - $2.81
52 Week Range $1.15 - $3.15
Shares Outstanding 200.37M
Change % -0.18%
Net Change ▼ -0.0050
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year1997
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -54,880.00

Date Type Amount Purchased Purchaser
2025-08-25 Buy 25000.00 Gregory Dean A.
2025-01-02 Buy 1725.00 Gregory Dean A.
2024-08-07 Sale -21605.00 Benjamin Richard J
2024-07-02 Sale -60000.00 Gregory Dean A.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025
4 Insider transactions 1 Jun 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy